Literature DB >> 20186695

Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.

Ling Cao1, Xu Dong Zhou, Mary Ann Sens, Scott H Garrett, Yun Zheng, Jane R Dunlevy, Donald A Sens, Seema Somji.   

Abstract

This laboratory has shown that arsenite (As(+3)) exposure can cause the malignant transformation of the UROtsa human urothelial cell line. This single isolate formed subcutaneous tumors with a histology similar to human urothelial cell carcinoma. The tumors also displayed areas of squamous differentiation of the urothelial cells, an infrequent but known component of human bladder cancer. In the present study, five additional independent isolates of As(+3)-transformed urothelial cells were isolated and each was shown to produce subcutaneous urothelial cell tumors with a characteristic histology very similar to those described in the initial report. That there were underlying phenotypic differences in the six independent isolates was demonstrated when they were assessed for their ability to form tumors within the peritoneal cavity. It was shown that two isolates could form hundreds of small peritoneal tumor nodules, one isolate a moderate number of tumor nodules, and three isolates no or only one tumor nodule. The peritoneal tumors were also characterized for their degree of squamous differentiation of the urothelial cells and, while areas of squamous differentiation could be found, such differentiation was substantially reduced compared to subcutaneous tumors. Immunostaining for keratin 6 was tested as a potential marker for malignant urothelial cells that had undergone squamous differentiation. Keratin 6 was shown to consistently stain only cells having some evidence of squamous differentiation. Keratin 16 was shown to follow the staining pattern of keratin 6. The isolates and tumor heterotransplants were all examined for keratin 6, 16 and 17 mRNA and protein expression. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186695      PMCID: PMC3100548          DOI: 10.1002/jat.1513

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  32 in total

1.  Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.

Authors:  C J Logothetis; F H Dexeus; C Chong; A Sella; A G Ayala; J Y Ro; S Pilat
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

2.  Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; J P Blandy; S I Baithun
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

3.  A survey of growth in soft agar and cell surface properties as markers for transformation in adult rat liver epithelial-like cell cultures.

Authors:  R H San; M F Laspia; A I Soiefer; C J Maslansky; J M Rice; G M Williams
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

4.  The impact of squamous metaplasia in transitional cell carcinoma of the bladder.

Authors:  A Akdaş; L Türkeri
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 5.  Arsenic and urinary bladder cell proliferation.

Authors:  Michael I Luster; Petia P Simeonova
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

6.  Ingested arsenic and internal cancer: a historical cohort study followed for 33 years.

Authors:  T Tsuda; A Babazono; E Yamamoto; N Kurumatani; Y Mino; T Ogawa; Y Kishi; H Aoyama
Journal:  Am J Epidemiol       Date:  1995-02-01       Impact factor: 4.897

7.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

8.  Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.

Authors:  F Smedts; F Ramaekers; R E Leube; K Keijser; M Link; P Vooijs
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

9.  The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.

Authors:  H A Frazier; J E Robertson; R K Dodge; D F Paulson
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

10.  Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.

Authors:  R A Weiss; R Eichner; T T Sun
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  22 in total

1.  Increased neuron specific enolase expression by urothelial cells exposed to or malignantly transformed by exposure to Cd²⁺ or As³⁺.

Authors:  Maureen Soh; Jane R Dunlevy; Scott H Garrett; Christina Allen; Donald A Sens; Xu Dong Zhou; Mary Ann Sens; Seema Somji
Journal:  Toxicol Lett       Date:  2012-05-14       Impact factor: 4.372

2.  Beclin-1 expression in normal bladder and in Cd2+ and As3+ exposed and transformed human urothelial cells (UROtsa).

Authors:  Jennifer L Larson; Seema Somji; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Donald A Sens; Jane R Dunlevy
Journal:  Toxicol Lett       Date:  2010-03-03       Impact factor: 4.372

3.  Enrichment of genes associated with squamous differentiation in cancer initiating cells isolated from urothelial cells transformed by the environmental toxicant arsenite.

Authors:  Zachary E Hoggarth; Danyelle B Osowski; Andrea Slusser-Nore; Swojani Shrestha; Prakash Pathak; Theoren Solseng; Scott H Garrett; Divyen H Patel; Evan Savage; Donald A Sens; Seema Somji
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-29       Impact factor: 4.219

4.  The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.

Authors:  Andrea Slusser-Nore; Scott H Garrett; Xu Dong Zhou; Donald A Sens; Mary Ann Sens; Seema Somji
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-10       Impact factor: 4.219

5.  KRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosis.

Authors:  Haoxuan Zhang; Mingsheng Huo; Yin Jia; Ao Xu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Kindlin-2 expression in arsenite- and cadmium-transformed bladder cancer cell lines and in archival specimens of human bladder cancer.

Authors:  Sherine Talaat; Seema Somji; Conrad Toni; Scott H Garrett; Xu Dong Zhou; Mary Ann Sens; Donald A Sens
Journal:  Urology       Date:  2011-06       Impact factor: 2.649

7.  SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite.

Authors:  Jennifer Larson; Tahmina Yasmin; Donald A Sens; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Jane R Dunlevy; Ling Cao; Seema Somji
Journal:  Toxicol Lett       Date:  2010-09-16       Impact factor: 4.372

8.  Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.

Authors:  Ruowen Zhang; Liping Wang; Scott H Garrett; Donald A Sens; Jane R Dunlevy; Xu Dong Zhou; Seema Somji
Journal:  Exp Toxicol Pathol       Date:  2016-08-13

9.  Human renal tubular cells contain CD24/CD133 progenitor cell populations: Implications for tubular regeneration after toxicant induced damage using cadmium as a model.

Authors:  Swojani Shrestha; Seema Somji; Donald A Sens; Andrea Slusser-Nore; Divyen H Patel; Evan Savage; Scott H Garrett
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-03       Impact factor: 4.219

10.  Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients.

Authors:  Tamilselvi Elango; Haripriya Dayalan; Pushpa Gnanaraj; Hemamalini Malligarjunan; Swapna Subramanian
Journal:  Clin Exp Med       Date:  2013-08-15       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.